NEIL GARRY ARTHUR 4
4 · Avalo Therapeutics, Inc. · Filed Feb 15, 2023
Insider Transaction Report
Form 4
NEIL GARRY ARTHUR
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-13+100,000→ 100,000 totalExercise: $2.98Exp: 2033-02-13→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each applicable vesting date.